Venrock Adviser, LLC
Source: SEC Form 13F · as of Mar 2026Venrock Adviser, LLC holds 23 biotech & pharma companies tracked by BioSniper, totaling $2.19B in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$2.19B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Apogee Therapeutics, Inc. (APGE)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| APGEApogee Therapeutics, Inc. | 8,493,321 | $714.9M |
| ORKAOruka Therapeutics, Inc. | 4,148,428 | $203.5M |
| SYRESpyre Therapeutics, Inc. | 3,685,448 | $185.9M |
| KALVKalVista Pharmaceuticals, Inc. | 6,474,485 | $130.3M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 1,180,000 | $99.0M |
| DMRADamora Therapeutics, Inc. | 3,603,595 | $93.3M |
| OCULOCULAR THERAPEUTIX, INC | 10,346,926 | $87.6M |
| COGTCogent Biosciences, Inc. | 2,000,000 | $77.0M |
| VRDNViridian Therapeutics, Inc.\DE | 3,882,709 | $75.9M |
| SVRASavara Inc | 13,740,375 | $75.0M |
| ELVNEnliven Therapeutics, Inc. | 1,726,331 | $67.7M |
| ORICOric Pharmaceuticals, Inc. | 4,319,765 | $54.7M |
| MAZEMaze Therapeutics, Inc. | 1,602,034 | $47.8M |
| CTMXCytomX Therapeutics, Inc. | 9,982,124 | $46.9M |
| JBIOJade Biosciences, Inc. | 3,220,364 | $45.2M |
| CBIOCRESCENT BIOPHARMA, INC. | 2,133,576 | $39.2M |
| ZURAZura Bio Ltd | 6,434,990 | $38.3M |
| RLMDRELMADA THERAPEUTICS, INC. | 4,843,380 | $33.7M |
| TENXTENAX THERAPEUTICS, INC. | 1,675,262 | $26.8M |
| CGEMCullinan Therapeutics, Inc. | 1,379,965 | $19.6M |
| SRZNSurrozen Inc. | 632,931 | $18.4M |
| KRROKorro Bio, Inc. | 1,009,500 | $11.4M |
| XFORX4 Pharmaceuticals, Inc | 330,525 | $1.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.